Compare Bank of Montreal (BMO) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs Enveric Biosciences Inc — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: Bank of Montreal is far larger — about 23285.4× Enveric Biosciences Inc's market cap, and Bank of Montreal pays a 2.77% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| BMO | ENVB | |
|---|---|---|
Market Cap | $124.81B | $5.36M |
Sector | Financials | Health |
52-Week High | $180.86 | $17.40 |
52-Week Low | $110.44 | $1.28 |
Dividend Yield | 2.77% | — |
Enterprise Value | — | $449.11K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
